PMID- 32720864 OWN - NLM STAT- MEDLINE DCOM- 20210119 LR - 20210119 IS - 1607-8454 (Electronic) IS - 1024-5332 (Linking) VI - 25 IP - 1 DP - 2020 Dec TI - Analysis of rare thalassemia caused by HS-40 regulatory site deletion. PG - 286-291 LID - 10.1080/16078454.2020.1799587 [doi] AB - ABSTRACT Objectives: To investigate the effect of HS-40 regulatory site deletion on alpha-globin gene expression and its clinical significance. Methods: Venous blood samples of subjects were analyzed using a hematology analyzer and high- performance liquid chromatography; fetal cord blood was analyzed by a capillary electrophoresis analyzer. Gap-polymerase chain reaction (PCR), reverse dot blot (RDB), and multiple-link-dependent probe amplification (MLPA) were used for genotyping of thalassemia. Results: The proband was POLR3 K, HS-40 heterozygous deletion; the proband's wife was -SEA/alphaalpha; the fetus was POLR3 K, HS-40 heterozygous deletion combined with -SEA deletion; all of them had microcytic hypochromic anemia. Fetal umbilical cord blood electrophoresis revealed a suspected Hb Bart's band to be 88.4%, and the fetus was, thus, diagnosed as Hb Bart's fetus. The red blood cell parameters of the sporadic case showed that he had microcytic hypochromic anemia. Hemoglobin (Hb) electrophoresis analysis showed Hb H to be 5.3%, leading to a diagnosis of Hb H disease. Gap-PCR and RDB identified the genotype to be -alpha3.7/alphaalpha, beta(A)/beta(A). MLPA detected heterozygous deletion or -alpha3.7 deletion on one allele and deletion of the HS-40 regulatory site on the other allele. Conclusion: The deletion of HS-40 regulatory site reduced expression of alpha-globin. HS-40 heterozygous deletion manifested as mild anemia, which was of microcytic hypochromic type. When compounded with -alpha3.7/alphaalpha, it manifested as Hb H disease; and when compounded with -SEA/alphaa, it manifested as Hb Bart's fetus. FAU - Luo, Shiqiang AU - Luo S AD - Department of Medical Genetics, Liuzhou Maternal and Child Health Hospital, Liuzhou, People's Republic of China. FAU - Chen, Xingyuan AU - Chen X AD - Department of Laboratory Medicine, Guangxi Zhuang Autonomous Region People's Hospital, Nanning, People's Republic of China. FAU - Zhong, Qingyan AU - Zhong Q AD - Department of Medical Genetics, Liuzhou Maternal and Child Health Hospital, Liuzhou, People's Republic of China. FAU - Wang, Qiuhua AU - Wang Q AD - Department of Medical Genetics, Liuzhou Maternal and Child Health Hospital, Liuzhou, People's Republic of China. FAU - Xu, Zehui AU - Xu Z AD - Department of Medical Genetics, Liuzhou Maternal and Child Health Hospital, Liuzhou, People's Republic of China. FAU - Qin, Liuqun AU - Qin L AD - Department of Medical Genetics, Liuzhou Maternal and Child Health Hospital, Liuzhou, People's Republic of China. FAU - Wang, Jingren AU - Wang J AD - Department of Medical Genetics, Liuzhou Maternal and Child Health Hospital, Liuzhou, People's Republic of China. FAU - Yuan, Dejian AU - Yuan D AD - Department of Medical Genetics, Liuzhou Maternal and Child Health Hospital, Liuzhou, People's Republic of China. FAU - Yan, Tizhen AU - Yan T AD - Department of Medical Genetics, Liuzhou Maternal and Child Health Hospital, Liuzhou, People's Republic of China. FAU - Tang, Ning AU - Tang N AD - Department of Medical Genetics, Liuzhou Maternal and Child Health Hospital, Liuzhou, People's Republic of China. LA - eng PT - Case Reports PT - Journal Article PL - England TA - Hematology JT - Hematology (Amsterdam, Netherlands) JID - 9708388 RN - 0 (Hemoglobins, Abnormal) RN - 0 (alpha-Globins) RN - 9056-09-1 (hemoglobin Bart's) SB - IM MH - Adult MH - Alleles MH - Anemia, Hypochromic/diagnosis/genetics MH - Base Sequence MH - Female MH - Hemoglobins, Abnormal/chemistry/*genetics MH - Heterozygote MH - Humans MH - Male MH - Pedigree MH - Pregnancy MH - Prenatal Diagnosis MH - Sequence Deletion MH - alpha-Globins/chemistry/*genetics MH - alpha-Thalassemia/*diagnosis/genetics OTO - NOTNLM OT - Family pedigree analysis OT - HS-40 OT - Hb Bart's fetus OT - Hb H OT - People's Republic of China OT - Phenotype OT - Thalassemia OT - rare type of thalassemia EDAT- 2020/07/29 06:00 MHDA- 2021/01/20 06:00 CRDT- 2020/07/29 06:00 PHST- 2020/07/29 06:00 [entrez] PHST- 2020/07/29 06:00 [pubmed] PHST- 2021/01/20 06:00 [medline] AID - 10.1080/16078454.2020.1799587 [doi] PST - ppublish SO - Hematology. 2020 Dec;25(1):286-291. doi: 10.1080/16078454.2020.1799587.